Search results
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 14 hours agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment ...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 7 hours agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters· 7 hours ago, opens new tab gene therapy for hemophilia B on Friday, the second such therapy for the rare...
US approves gene therapy treatment for hemophilia
Medical Xpress· 12 hours agoPharmaceutical giant Pfizer has received US approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 16 hours agoDive Brief: The Food and Drug Administration on Friday approved a new gene therapy for hemophilia,...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 7 hours agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Scientists report that new gene therapy slows down amyotrophic lateral sclerosis disease progression
Medical Xpress· 11 hours agoThere has been a breakthrough in the research on the disease amyotrophic lateral sclerosis (ALS)....
Gene Therapy Trial for Sickle Cell Disease Publishes Final Results
Technology Networks· 1 day agoIn a landmark study, an international consortium led by researchers at Children’s Hospital of...
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT)...
Market Watch· 22 hours agoSensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a significant global ...
Cantor Fitzgerald Reaffirms “Overweight” Rating for Taysha Gene Therapies (NASDAQ:TSHA)
ETF DAILY NEWS· 6 days agoCantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report released on Thursday, Benzinga reports. They currently have a $7.00 ...